GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » EV-to-EBITDA

Decipher Labs (BOM:524752) EV-to-EBITDA : -1.12 (As of May. 24, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Decipher Labs's enterprise value is ₹64.4 Mil. Decipher Labs's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-57.3 Mil. Therefore, Decipher Labs's EV-to-EBITDA for today is -1.12.

The historical rank and industry rank for Decipher Labs's EV-to-EBITDA or its related term are showing as below:

BOM:524752' s EV-to-EBITDA Range Over the Past 10 Years
Min: -4888.89   Med: 0.75   Max: 20647.05
Current: -1.13

During the past 13 years, the highest EV-to-EBITDA of Decipher Labs was 20647.05. The lowest was -4888.89. And the median was 0.75.

BOM:524752's EV-to-EBITDA is ranked worse than
100% of 713 companies
in the Drug Manufacturers industry
Industry Median: 14.45 vs BOM:524752: -1.13

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-24), Decipher Labs's stock price is ₹14.93. Decipher Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-194.940. Therefore, Decipher Labs's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Decipher Labs EV-to-EBITDA Historical Data

The historical data trend for Decipher Labs's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs EV-to-EBITDA Chart

Decipher Labs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.09 9.25 10.55 3.53 -2.38

Decipher Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 -2.38 -1.88 -0.68 -3.07

Competitive Comparison of Decipher Labs's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Decipher Labs's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decipher Labs's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Decipher Labs's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Decipher Labs's EV-to-EBITDA falls into.



Decipher Labs EV-to-EBITDA Calculation

Decipher Labs's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=64.427/-57.314
=-1.12

Decipher Labs's current Enterprise Value is ₹64.4 Mil.
Decipher Labs's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-57.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Decipher Labs  (BOM:524752) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Decipher Labs's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.93/-194.940
=At Loss

Decipher Labs's share price for today is ₹14.93.
Decipher Labs's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-194.940.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Decipher Labs EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Decipher Labs's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs (BOM:524752) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs (BOM:524752) Headlines

No Headlines